CN Stock MarketDetailed Quotes
600479 Zhuzhou Qianjin Pharmaceutical
- 10.84
- -0.12-1.09%
Market Closed Dec 30 15:00 CST
4.60BMarket Cap15.76P/E (TTM)
10.97High10.81Low61.40KlotVolume10.96Open10.96Pre Close66.73MTurnover1.47%Turnover Ratio14.34P/E (Static)424.00MShares13.8952wk High1.91P/B4.54BFloat Cap8.2452wk Low12.06Limit Up418.51MShs Float22.69Historical High9.86Limit Down1.46%Amplitude-3.64Historical Low0.35Dividend TTM10.87Avg Price35.87KlotAsk3.23%Div YieldTTM100Lot Size22.46KlotBid
Zhuzhou Qianjin Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 2.66%1.73B | 26.35%1.71B | 28.86%1.8B | 61.13%2B | 88.89%1.69B | 49.37%1.35B | 99.43%1.4B | 95.92%1.24B | 74.30%892.36M | 59.29%906.71M |
| Transactional financial assets | --3.58M | ---- | ---- | ---- | --0 | -91.00%50.32M | -77.77%150.28M | -33.26%491.74M | -27.11%542.28M | 2.63%558.95M |
| Notes receivable and accounts receivable | 5.58%627.12M | 9.88%658.23M | 8.55%706.61M | 1.07%553.94M | -2.46%593.98M | 0.44%599.05M | 3.13%650.95M | 6.78%548.09M | 90.12%608.97M | 65.57%596.43M |
| -Notes receivable | 20.86%261.19M | 34.00%259.51M | 29.75%322.39M | 3.73%303.54M | -9.86%216.12M | -14.54%193.67M | -1.41%248.48M | 1.06%292.64M | --239.77M | --226.61M |
| -Accounts receivable | -3.16%365.93M | -1.64%398.72M | -4.53%384.22M | -1.98%250.4M | 2.35%377.86M | 9.62%405.39M | 6.15%402.47M | 14.18%255.45M | 15.27%369.2M | 2.66%369.82M |
| Other receivables (including interest and dividends) | -25.96%88.52M | -4.53%118.1M | 13.96%131.32M | 1.53%28.26M | 4.71%119.56M | 2.73%123.71M | -15.64%115.24M | -10.89%27.83M | -24.78%114.18M | -10.05%120.42M |
| -Other receivable | ---- | -4.53%118.1M | ---- | ---- | ---- | 2.73%123.71M | ---- | -10.89%27.83M | ---- | -10.05%120.42M |
| Advance payment | 70.52%56.38M | -52.52%26.35M | -35.02%40.54M | -75.92%26.22M | -54.50%33.06M | 36.92%55.51M | 10.89%62.39M | 83.15%108.89M | -12.88%72.66M | -0.39%40.54M |
| Inventories | -11.92%494.98M | -5.68%547.84M | -11.21%550.69M | -10.83%534.14M | 6.80%561.97M | 11.45%580.84M | 20.41%620.2M | 9.35%598.99M | 4.93%526.2M | -2.94%521.16M |
| Receivable financing | -11.28%298.76M | -20.35%254.77M | 23.34%329.43M | 19.90%358.6M | 32.52%336.73M | 24.21%319.88M | -12.29%267.1M | -5.84%299.08M | -54.91%254.1M | -49.01%257.53M |
| Other current assets | -65.33%23.21M | -85.65%26.26M | -90.49%15.86M | -92.24%15.43M | -66.08%66.95M | 917.62%182.96M | 536.53%166.72M | 154.55%198.91M | 175.28%197.4M | -74.44%17.98M |
| Total current assets | -2.20%3.32B | 2.33%3.34B | 4.22%3.57B | 0.03%3.51B | 5.91%3.4B | 8.18%3.27B | 12.58%3.43B | 20.44%3.51B | 8.82%3.21B | 9.37%3.02B |
| Non Current assets | ||||||||||
| Other equity investment | 523.85%59.42M | 542.08%59.52M | 515.38%59.52M | 675.83%59.52M | 21.01%9.52M | 17.77%9.27M | -12.14%9.67M | -30.28%7.67M | -28.47%7.87M | -28.46%7.87M |
| Other non-current financial assets | 1.49%55.83M | 12.51%60.26M | 1.65%58.36M | 0.26%57.37M | 0.64%55.01M | 1.63%53.56M | 7.47%57.41M | 7.10%57.23M | 1.58%54.66M | 1.22%52.7M |
| Long-term equity investment | 3.33%127.39M | 3.11%127.68M | 5.64%127.99M | 6.54%130.72M | 5.99%123.28M | 1.75%123.82M | -4.16%121.16M | -2.88%122.7M | -7.88%116.32M | -2.79%121.69M |
| Fixed assets | ---- | -5.91%512.93M | ---- | ---- | ---- | 24.68%545.17M | ---- | 21.58%557.72M | ---- | -3.94%437.26M |
| Fixed assets liquidation | ---- | ---- | ---- | ---- | ---- | 110.12%11.36K | ---- | -89.44%1.81K | ---- | 99.48%-112.31K |
| Constru in process | ---- | 12.80%10.88M | ---- | ---- | ---- | -91.58%9.65M | ---- | -93.88%5.78M | ---- | 143.12%114.64M |
| Intangible assets | 5.24%208.95M | 7.85%206.28M | 8.42%209.23M | 8.76%212.21M | 0.89%198.55M | -3.61%191.26M | -3.60%192.98M | -3.36%195.11M | -3.20%196.79M | -2.91%198.41M |
| Development expenditure | -22.21%18.82M | -47.92%15.01M | -43.19%15.76M | -2.44%26.06M | 2.98%24.2M | 39.39%28.83M | 53.16%27.75M | 50.69%26.72M | 62.67%23.5M | 99.97%20.68M |
| Goodwill | 0.00%14.07M | 0.00%14.07M | 0.00%14.07M | 0.00%14.07M | 0.00%14.07M | 0.00%14.07M | 0.00%14.07M | 0.00%14.07M | 0.00%14.07M | 0.00%14.07M |
| Long deferred expense | -13.28%42.64M | 20.21%48.22M | 28.15%53M | 2.16%45.66M | 1.68%49.18M | -23.15%40.11M | -26.00%41.36M | -24.57%44.69M | -29.33%48.36M | -27.77%52.19M |
| Deferred tax assets | 158.00%26.19M | 187.46%27.35M | 191.41%26.46M | 17.52%22.67M | 11.64%10.15M | 44.31%9.51M | 20.91%9.08M | 367.60%19.29M | 56.23%9.09M | 13.26%6.59M |
| Usufruct assets | 11.23%53.85M | 22.86%59.64M | 12.81%59.94M | -5.27%56.13M | -21.40%48.42M | -26.13%48.55M | -25.27%53.13M | -23.17%59.25M | 8.07%61.6M | 6.39%65.72M |
| Other non current assets | -54.06%10.17M | -48.45%9.74M | -62.71%6.16M | -61.65%4.18M | -18.94%22.13M | -30.01%18.89M | -33.57%16.53M | -56.23%10.91M | -52.66%27.3M | -51.08%26.99M |
| Total non current assets | 3.51%1.13B | 5.39%1.15B | 5.45%1.16B | 3.68%1.16B | -1.69%1.09B | -2.33%1.09B | -2.98%1.1B | -1.91%1.12B | -1.24%1.11B | 2.36%1.12B |
| Total assets | -0.81%4.45B | 3.10%4.49B | 4.52%4.74B | 0.91%4.68B | 3.96%4.49B | 5.34%4.36B | 8.36%4.53B | 14.15%4.63B | 6.04%4.32B | 7.38%4.14B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -67.59%15.75M | 1.06%45.97M | -18.61%41.95M | -2.49%56.69M | -26.51%48.61M | -37.51%45.49M | -22.33%51.54M | -13.35%58.13M | -0.53%66.14M | 41.15%72.79M |
| Notes payable and accounts payable | -13.21%541.52M | -2.66%607.17M | -5.44%722.2M | -17.09%647.49M | -11.48%623.92M | -6.19%623.76M | 31.27%763.7M | 52.62%780.92M | 8.99%704.81M | 13.05%664.9M |
| -Notes payable | -16.98%230.98M | -9.99%241.35M | -8.42%352.22M | -23.68%353.15M | -19.86%278.22M | -14.18%268.13M | 55.55%384.62M | 93.93%462.71M | 9.68%347.17M | 19.55%312.43M |
| -Accounts payable | -10.17%310.54M | 2.87%365.82M | -2.40%369.98M | -7.50%294.34M | -3.34%345.7M | 0.89%355.62M | 13.32%379.08M | 16.53%318.21M | 8.33%357.64M | 7.85%352.48M |
| Contract liabilities | -11.69%73.54M | -19.83%66.29M | -6.20%82.93M | -5.79%123.61M | 9.99%83.28M | 1.74%82.69M | 45.95%88.41M | 31.75%131.21M | -3.12%75.71M | 13.14%81.27M |
| Salaries payable | 7.52%104.59M | -12.92%71.65M | 35.73%64.99M | 18.12%187.69M | 75.74%97.28M | 64.16%82.28M | 33.19%47.88M | 26.64%158.9M | 3.46%55.36M | 77.04%50.12M |
| Taxs payable | -29.43%39.68M | -11.07%27.38M | 0.27%60.43M | -2.70%70.57M | -22.66%56.23M | -29.59%30.79M | 64.01%60.27M | 103.78%72.53M | 34.14%72.7M | 25.06%43.73M |
| Other payable (including interest and dividends) | -17.91%429.83M | -12.65%455.93M | 3.34%475.78M | -5.45%365.14M | 9.07%523.6M | 16.60%521.94M | 7.99%460.39M | 32.26%386.19M | 12.12%480.05M | 5.87%447.65M |
| -Dividend payable | 3.24%1.06M | -94.13%2.98M | 1,409.65%15.14M | 2.47%1.03M | 2.47%1.03M | 4,963.75%50.78M | 3.86%1M | 3.86%1M | -87.19%1M | -94.76%1M |
| -Other payable | ---- | -3.87%452.95M | ---- | ---- | ---- | 5.49%471.16M | ---- | 32.35%385.19M | ---- | 10.65%446.65M |
| Non current liabilities due within one year | 35.85%27.08M | 36.50%26.86M | 16.74%25.41M | 0.99%21.56M | -1.06%19.93M | -3.78%19.68M | -7.41%21.76M | -0.97%21.34M | -12.48%20.15M | -11.15%20.45M |
| Other current liabilities | 7.37%64.46M | 24.92%90.58M | 25.36%78.44M | -21.51%69.07M | -24.89%60.04M | -7.20%72.51M | -18.57%62.57M | 16.60%87.99M | 58.13%79.93M | 39.55%78.14M |
| Total current liabilities | -14.31%1.3B | -5.90%1.39B | -0.28%1.55B | -9.16%1.54B | -2.70%1.51B | 1.38%1.48B | 18.99%1.56B | 38.16%1.7B | 11.00%1.55B | 14.29%1.46B |
| Current liabilities | ||||||||||
| Long term loan | -60.00%4M | -60.00%4M | -41.67%7M | -41.67%7M | -28.57%10M | -28.57%10M | -22.58%12M | -22.58%12M | -17.65%14M | -17.65%14M |
| Long term account payable | ---- | 0.00%5.19M | ---- | ---- | ---- | 0.00%5.19M | ---- | 0.00%5.19M | ---- | 0.00%5.19M |
| Deferred tax liabilities | 95.49%25.33M | 108.35%27.13M | 137.42%27.66M | 2.76%24.72M | 9.42%12.96M | 0.75%13.02M | -8.44%11.65M | 81.91%24.06M | 8.16%11.84M | 18.12%12.92M |
| Long term deferred income | -17.95%32.67M | -19.30%33.56M | -14.92%36.35M | -14.40%38.04M | -13.95%39.81M | -13.49%41.59M | -13.38%42.72M | -13.32%44.44M | -13.09%46.27M | -1.70%48.07M |
| Lease liabilities | 5.13%25.07M | 33.86%31.73M | 24.97%31.83M | -3.97%31.46M | -26.48%23.85M | -32.99%23.7M | -34.77%25.47M | -26.84%32.76M | -14.54%32.44M | -16.28%35.37M |
| Other non current liabilities | 0.00%1.9M | 0.00%1.9M | 0.00%1.9M | 0.00%1.9M | 0.00%1.9M | 0.00%1.9M | 0.00%1.9M | 0.00%1.9M | 0.00%1.9M | 0.00%1.9M |
| Total non current liabilities | 0.48%94.16M | 8.50%103.51M | 11.11%109.92M | -10.00%108.32M | -16.06%93.72M | -18.78%95.4M | -20.01%98.93M | -8.74%120.36M | -11.56%111.64M | -6.92%117.46M |
| Total liabilities | -13.44%1.39B | -5.03%1.5B | 0.40%1.66B | -9.21%1.65B | -3.59%1.61B | -0.13%1.57B | 15.62%1.66B | 33.61%1.82B | 9.14%1.67B | 12.38%1.58B |
| Shareholders equity | ||||||||||
| Paid-in capital | -1.25%424M | -1.28%424M | -0.23%428.92M | -0.21%428.92M | -0.11%429.35M | -0.07%429.51M | 0.02%429.89M | 2.70%429.81M | 2.70%429.81M | 2.70%429.81M |
| Capital reserve funds | -4.44%616.44M | -4.01%616.42M | -1.08%632.68M | -0.67%631.18M | 1.38%645.11M | 1.85%642.17M | 2.70%639.6M | 8.53%635.44M | 8.69%636.33M | 7.70%630.53M |
| Surplus reserve funds | 0.00%220.55M | 0.00%220.55M | 0.00%220.55M | 0.00%220.55M | 2.63%220.55M | 2.63%220.55M | 2.63%220.55M | 2.63%220.55M | 0.00%214.9M | 0.00%214.9M |
| Retained profit | 14.64%1.17B | 19.09%1.12B | 17.14%1.19B | 17.59%1.14B | 18.34%1.02B | 19.02%937.44M | 4.53%1.01B | 4.39%971.59M | 5.15%860.03M | 7.56%787.6M |
| Less:Treasury stock | -54.59%16.56M | -55.25%16.56M | -17.12%35.02M | -16.25%35.02M | -12.80%36.46M | -11.52%36.99M | -13.05%42.25M | --41.81M | --41.81M | --41.81M |
| Other composite income | -4.97%1.51M | 13.35%1.59M | 13.17%1.59M | 13.21%1.59M | 2.56%1.59M | -9.75%1.4M | 85.54%1.4M | 86.55%1.4M | 106.50%1.55M | 106.70%1.55M |
| Shareholders equity without minority interests | 5.92%2.41B | 7.67%2.36B | 7.66%2.44B | 7.79%2.39B | 8.43%2.28B | 8.48%2.19B | 3.36%2.26B | 3.10%2.22B | 3.11%2.1B | 3.62%2.02B |
| Minority interests | 7.39%650.56M | 7.77%636.63M | 4.06%637.77M | 6.17%637.08M | 9.72%605.81M | 9.53%590.74M | 9.33%612.91M | 9.19%600.07M | 8.50%552.16M | 8.04%539.33M |
| Total shareholder equity | 6.23%3.06B | 7.69%3B | 6.89%3.08B | 7.44%3.03B | 8.70%2.88B | 8.70%2.78B | 4.57%2.88B | 4.34%2.82B | 4.18%2.65B | 4.52%2.56B |
| Total liabilityies and equity | -0.81%4.45B | 3.10%4.49B | 4.52%4.74B | 0.91%4.68B | 3.96%4.49B | 5.34%4.36B | 8.36%4.53B | 14.15%4.63B | 6.04%4.32B | 7.38%4.14B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
